[HTML][HTML] Imatinib inhibits SARS-CoV-2 infection by an off-target-mechanism

R Strobelt, J Adler, N Paran, Y Yahalom-Ronen… - Scientific reports, 2022 - nature.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causal agent of
the COVID-19 pandemic. More than 274 million individuals have suffered from COVID-19 …

[HTML][HTML] Role of biochemical markers in the monitoring of COVID-19 patients

P Letelier, N Encina, P Morales, A Riffo… - Journal of medical …, 2021 - ncbi.nlm.nih.gov
COVID-19 is an infectious disease caused by the SARSCoV-2 virus, which has given rise to
a global sanitary emergency. The clinical characteristics of COVID-19 are varied and can …

Learning through a pandemic: the current state of knowledge on COVID-19 and cancer

A Elkrief, JT Wu, C Jani, KT Enriquez, M Glover… - Cancer discovery, 2022 - AACR
The ongoing coronavirus disease 2019 (COVID-19) pandemic has left patients with current
or past history of cancer facing disparate consequences at every stage of the cancer …

Anti‐SARS‐CoV‐2 IgG levels in relation to disease severity of COVID‐19

X Yan, G Chen, Z Jin, Z Zhang, B Zhang… - Journal of medical …, 2022 - Wiley Online Library
The durability of infection‐induced severe acute respiratory syndrome coronavirus 2 (SARS‐
CoV‐2) immunity has crucial implications for reinfection and vaccine effectiveness …

Exploring the immunogenic properties of SARS-CoV-2 structural proteins: PAMP: TLR signaling in the mediation of the neuroinflammatory and neurologic sequelae of …

MG Frank, M Fleshner, SF Maier - Brain, Behavior, and Immunity, 2023 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) produces an array of
neurologic and neuropsychiatric symptoms in the acute and post-acute phase of infection …

[HTML][HTML] COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challenges

GR Sivandzadeh, H Askari, AR Safarpour… - World journal of …, 2021 - ncbi.nlm.nih.gov
It is hypothesized that liver impairment caused by coronavirus disease 2019 (COVID-19)
infection might play a central role in severe clinical presentations. Liver injury is closely …

[HTML][HTML] Hemorrhagic and ischemic stroke in patients with coronavirus disease 2019: incidence, risk factors, and pathogenesis-a systematic review and meta-analysis

S Syahrul, HA Maliga, M Ilmawan, M Fahriani… - …, 2021 - ncbi.nlm.nih.gov
Background: In this study, we aimed to determine the global prevalence, chronological order
of symptom appearance, and mortality rates with regard to hemorrhagic and ischemic stroke …

The preventive effect of Xuebijing injection against cytokine storm for severe patients with COVID-19: a prospective randomized controlled trial

Z Luo, W Chen, M Xiang, H Wang, W Xiao, C Xu… - European journal of …, 2021 - Elsevier
Introduction COVID-19 is severely affecting countries globally and mortality is high.
Xuebijing (XBJ) injection is widely used in the treatment of severe pneumonia and sepsis in …

[HTML][HTML] Associations between COVID-19 infection and sex steroid hormones

Z Cai, J Zhong, Y Jiang, J Zhang - Frontiers in endocrinology, 2022 - frontiersin.org
Aims Coronavirus disease 2019 (COVID-19) is caused by infection with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), and within a few months of the first …

[HTML][HTML] Consequences of viral infection and cytokine production during pregnancy on brain development in offspring

D Elgueta, P Murgas, E Riquelme, G Yang… - Frontiers in …, 2022 - frontiersin.org
Infections during pregnancy can seriously damage fetal neurodevelopment by aberrantly
activating the maternal immune system, directly impacting fetal neural cells. Increasing …